Table of Contents

Psoriatic Arthritis Market Info: 2014 ™

Section One: Patients - Understanding Psoriatic Arthritis: Focuses on patients and how the disease affects their lives. Includes descriptive disease information, as well as epidemiology, diagnosis, quality of life for patients.

Section Two: Perspectives - Psoriatic Arthritis Management: A review of therapies, advantages and disadvantages, listing of major products and companies. Includes patients’ perspectives, experiences and insights on various therapies.

Summary: The major market drivers, including “What Makes the Psoriatic Arthritis Market Attractive,” “Six Most Important Facts About the PsA Market,” “Patient Insights” and a statement from the National Psoriasis Foundation (NPF).

Description

Psoriatic Arthritis Market Info: 2014 ™

Psoriatic Arthritis (PsA) is a form of arthritis frequently associated with psoriasis of the skin, which affects up to 30% of people with psoriasis. This chronic arthritis increases pain sensitivity while causing long-term joint damage and crippling. However, recent research shows early diagnosis and treatment can prevent PsA from becoming a debilitating and life-altering disease. The changing treatment paradigm is increasing market attractiveness and altering the competitive dynamic.

The 2014 Psoriatic Arthritis Market Info Report™ covers what you need to know about Psoriatic Arthritis, treatments and market value. This easy-to-follow slide deck provides the most recent 5-year market value update and captures explicit data on PsA which is often hard to obtain. In many cases, PsA disease and market information is “lumped” or buried within data for rheumatoid arthritis or psoriasis.